Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (CTX)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Columbia University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Elizabeth Shane, Columbia University
ClinicalTrials.gov Identifier:
NCT00297830
First received: February 27, 2006
Last updated: February 11, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2014
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Publications: